Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation
about
Genetic heterogeneity in response to adenovirus gene therapyPharmacogenetic heterogeneity of transgene expression in muscle and tumoursGammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk.Mouse adenovirus type 1 infection of natural killer cell-deficient miceHigh Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene TherapyIncreased sensitivity to staphylococcal enterotoxin B following adenoviral infectionImplications of the innate immune response to adenovirus and adenoviral vectors.Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancerThe role of NK cells and NK cell receptors in autoimmune disease.Innate immune response to adenovirus.Role of innate immunity in acetaminophen-induced hepatotoxicity.Adenoviral Expression of a Bispecific VHH-Based Neutralizing Agent That Targets Protective Antigen Provides Prophylactic Protection from Anthrax in MiceCD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis.Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm.Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver.CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines.Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.Identification of multiple genetic loci that regulate adenovirus gene therapy.MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo.Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A mice.
P2860
Q24796699-8755AC2E-0605-45FA-A179-4DBE6726245CQ24799710-E0FB7C8F-64C1-4123-AEC6-23EAD75A37D5Q30439944-F0E69BAA-C2EF-43C2-B4AE-3AD2D40221CCQ30439978-C50210F6-1236-438C-A7B5-CE0117665EA3Q33670765-CDAE6650-E79C-4A53-A657-2CC80CA55B2BQ33788137-0704C219-7F4B-45CE-99F2-AA2568E77358Q35085363-5666380C-A111-45E9-9C9D-E1832902781EQ35530297-1F21B2B7-E20E-431A-BF03-ACF5AC16CA30Q35672866-33610C9B-B337-4CD9-845A-0CCA08D5B9CFQ35855834-058D2DF5-0770-4151-B873-EF5057E950AEQ36278163-B72146B5-25FE-4C66-9AD2-82B97081F738Q36543087-4470ED59-883C-44AF-B88D-5AF1129CF999Q36665638-307DF657-D9D2-4DF6-A2C4-2BE31E8C5576Q36882248-5C44C7B3-7E14-4752-841E-3B6179B4B1A0Q37050672-82D07C00-14E8-4C5E-BF5F-6255904D32C1Q38008337-CD1C92D1-B15E-4764-A45D-857853A63C58Q39686745-5A69F8B2-95B0-4A10-BA0C-BA52F6D6FBEFQ42016952-7B945ABE-972F-4DAD-B3AF-73D520B93419Q42223027-026CB42E-7525-45BC-BB22-F54FE2675C99Q44175359-6C8F5366-2006-449A-8A13-E8487E1F13EBQ45732476-6BD1EAC5-F6F1-4390-A85C-1DA09B005E37Q45865139-A8D1CEA3-3D0D-43CE-BA85-FFD343D3A1C9Q45871591-58BCE229-3F69-4181-9A5F-A64D0218E2EB
P2860
Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Variation in adenovirus transg ...... duction and NK cell activation
@ast
Variation in adenovirus transg ...... duction and NK cell activation
@en
type
label
Variation in adenovirus transg ...... duction and NK cell activation
@ast
Variation in adenovirus transg ...... duction and NK cell activation
@en
prefLabel
Variation in adenovirus transg ...... duction and NK cell activation
@ast
Variation in adenovirus transg ...... duction and NK cell activation
@en
P2093
P2860
P1433
P1476
Variation in adenovirus transg ...... duction and NK cell activation
@en
P2093
E Falck-Pedersen
P2860
P304
P356
10.1128/JVI.75.10.4540-4550.2001
P577
2001-05-01T00:00:00Z